Skip to content

Drug interactions

Safinamide + Selexipag

Severity: Minor

Safinamide and Selexipag: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Selexipag is a BCRP substrate, and safinamide may inhibit BCRP in the gut. Selexipag exposure could increase modestly, with more prostacyclin-type adverse effects such as headache, diarrhea and jaw pain.

What this interaction means in plain words

Safinamide and Selexipag have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Safinamide belongs to Central Nervous System; Selexipag belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of intestinal BCRP efflux by safinamide may increase selexipag absorption.

What to do

No routine dose adjustment. Monitor for increased adverse effects of selexipag.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Safinamide and Selexipag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Safinamide with Selexipag?

MediHelp rates the interaction as minor. Safinamide and Selexipag have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Selexipag is a BCRP substrate, and safinamide may inhibit BCRP in the gut. Selexipag exposure could increase modestly, with more prostacyclin-type adverse effects such as headache, diarrhea and jaw pain.

How serious is the interaction between Safinamide and Selexipag?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose adjustment. Monitor for increased adverse effects of selexipag.

What other medicines interact with Safinamide?

MediHelp also lists interactions of Safinamide with, for example, Amitriptyline, Amoxapine, Amphetamine polistirex. The full list is on the Safinamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in